Pain Management

Sleep deprivation could increase sensitivity to pain.

Opioid use among Afghanistan, Iraq veterans similar to general population.

Recently we have received an increasing number of requests for consults on patients undergoing hemodialysis (HD) or with end-stage renal disease (ESRD).

The analgesic effects of alcohol could lead to a new class of painkillers.

OTC medications are typically not covered making them unaffordable and less accessible to the majority of the population.

After 3 days, patients treated with methadone during surgery no longer required opioids.

Having a few alcoholic beverages may be just as effective as some pain medications from the pharmacy, according to research from a new study.

Tighter regulations surrounding opioids have presented a challenge to physicians treating chronic pain.

Buprenorphine and naloxone buccal film (Bunavail) approved for a revised indication to include use for the initiation of buprenorphine treatment for opioid dependence.

Chronic pain has been defined by the International Association for the Study of Pain as pain that persists beyond the normal tissue healing time of 3 months, and it may be classified into 3 distinct categories: nociceptive, neuropathic, and a mixture of the two.

An interdisciplinary treatment modality is especially effective when treating patients with chronic pain.

Novel investigational compound observed to treat chronic pain without side effects.

A study led by UC Irvine and Duke University, presented at the 2017 American Academy of Pain Medicine meeting in Orlando, examined the association between opioid therapy and melanoma progression in patients diagnosed with the disease.

At the American Academy of Pain Medicine’s 2017 Annual Meeting, survey results were presented that revealed the implications of naloxone use in real-world experiences with the recently approved intranasal naloxone formulation.

The meeting theme this year, Pain as a Public Health Issue, emphasizes the extent to which pain affects the US population, with more than 100 million Americans suffering from pain.

To the dismay of many health care professionals, opioid abuse has become an epidemic in the United States.

Patients with low back pain should initially seek non-drug therapy.

Prescribers and pharmacists in various clinical roles are often challenged when treating patients with comorbid chronic pain and end-stage renal disease (ESRD) or hemodialysis (HD). There is a dearth of clinical guidelines available for chronic pain management in this setting. Those selecting pharmacotherapy for patients must rely on clinical judgement, literature analysis and prudent decision making.

On February 15 2017, Governor Chris Christie of New Jersey signed legislation aimed to curb the state’s opioid addiction epidemic

Before you read this article, take a moment and see if you remember the 7 or 8 black box warnings associated with long acting opioid pain medications.

Sixty percent to 90% of patients with cancer with bone metastasis develop bone pain. In turn, bone pain can be the first sign that cancer has spread to the bone.

$101 billion was spent on diabetes in 2013, which made it the top health spending category.

The survey found 65.5% of veterans experienced pain within the past 3 months.

Purdue and Shionogi will co-launch Symproic to treat opioid-induced constipation.

Officials with Elite Pharmaceuticals have filed an abbreviated new drug application with the FDA for a generic version of Norco (hydrocodone bitartrate and acetaminophen tablets) in doses of 2.5 mg/325 mg, 5 mg/325 mg, 7.5 mg/325 mg and 10 mg/325 mg.

AcelRX has submitted a New Drug Application (NDA) to the FDA for ARX-04 (sufentanil tablets).

Falls can cause significant mortality and morbidity in the aging population.

Egalet has submitted a supplemental new drug application (sNDA) to the FDA for Oxaydo, (oxycodone HCl, USP) in favor of an abuse-deterrent label claim for the intravenous route of abuse.

Top news of the day from across the healthcare landscape.